{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:47:50Z","timestamp":1757623670265,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jaclp.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T17:59:26Z","timestamp":1667757566000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["C-L Case Conference: Torsades de Pointes in a Patient With Lifelong Medical Trauma, COVID-19, Remdesivir, Citalopram, Quetiapine, and Hemodialysis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0677-8951","authenticated-orcid":false,"given":"Angela","family":"Landerholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie O.","family":"Fedotova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomi C.","family":"Levy-Carrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-4168","authenticated-orcid":false,"given":"Margo C.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1176\/appi.ajp.2019.1760501","article-title":"QTc prolongation and psychotropic medications","volume":"177","author":"Funk","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaclp.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaclp.2022.11.001_bib4","first-page":"353","article-title":"An analysis of time relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.jaclp.2022.11.001_bib5","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","author":"Vandenberk","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaclp.2022.11.001_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1542-474X.2003.08413.x","article-title":"The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920","volume":"8","author":"Fridericia","year":"2003","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib8","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1161\/CIRCULATIONAHA.108.191096","volume":"119","author":"Rautaharju","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jaclp.2022.11.001_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaclp.2021.02.003","article-title":"Assessment of QTc and risk of Torsades de Pointes in ventricular conduction delay and pacing: a review of the literature and call to action","volume":"62","author":"Funk","year":"2021","journal-title":"J\u00a0Acad Consult Liaison Psychiatry"},{"key":"10.1016\/j.jaclp.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcp.12726","article-title":"Pharmacological treatment of acquired QT prolongation and Torsades de Pointes","volume":"81","author":"Thomas","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"K111","DOI":"10.1016\/S0002-9149(00)01228-5","article-title":"Rate smoothing with cardiac pacing for preventing Torsade de Pointes","volume":"86","author":"Viskin","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.hrthm.2005.02.011","article-title":"Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one","volume":"2","author":"Viskin","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaclp.2022.11.001_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/phar.1242","article-title":"Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for Torsade de Pointes: a comparative, case-based evaluation","volume":"33","author":"Fongemie","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaclp.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 annual data report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaclp.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1681\/ASN.2018101032","article-title":"Comparative cardiac safety of selective serotonin reuptake inhibitors among individuals receiving maintenance hemodialysis","volume":"30","author":"Assimon","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155445","article-title":"Electrocardiographic abnormalities and QTc interval in patients undergoing hemodialysis","volume":"11","author":"Nie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaclp.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT prolongation, Torsades de Pointes, and psychotropic medications: a 5-year update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaclp.2022.11.001_bib19","doi-asserted-by":"crossref","first-page":"100379","DOI":"10.1016\/j.xkme.2021.08.013","article-title":"Serum potassium and mortality risk in hemodialysis patients: a cohort study","volume":"4","author":"de Rooij","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.jaclp.2022.11.001_bib21","first-page":"yty106","article-title":"Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier","volume":"2","author":"Marstrand","year":"2018","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jaclp.2022.11.001_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034560","article-title":"Drug use and torsades de pointes cardiac arrhythmias in Sweden: a nationwide register-based cohort study","volume":"10","author":"Danielsson","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaclp.2022.11.001_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239963","article-title":"Torsades de Pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications","volume":"14","author":"Aslam","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaclp.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/FPC.0b013e328346063f","article-title":"PharmGKB summary: citalopram pharmacokinetics pathway","volume":"21","author":"Sangkuhl","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaclp.2022.11.001_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s002280000205","article-title":"Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis","volume":"56","author":"Spigset","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0b013e31827c0314","article-title":"A\u00a0thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and\/or CYP3A4 and a comparison to quetiapine and ziprasidone","volume":"33","author":"Potkin","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaclp.2022.11.001_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10840-020-00789-9","article-title":"COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies","volume":"59","author":"Gopinathannair","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6842","article-title":"Cardiac corrected QT interval changes among patients treated for COVID-19 infection during the early phase of the pandemic","volume":"4","author":"Rubin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaclp.2022.11.001_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008627","article-title":"Cardiac arrest risk during acute infections","volume":"13","author":"Lazzerini","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41440-020-0476-3","article-title":"Downregulation of ACE2 induces overstimulation of the renin\u2013angiotensin system in COVID-19: should we block the renin\u2013angiotensin system?","volume":"43","author":"Silhol","year":"2020","journal-title":"Hypertens Res"},{"author":"Chen","key":"10.1016\/j.jaclp.2022.11.001_bib34"},{"key":"10.1016\/j.jaclp.2022.11.001_bib35","first-page":"3","article-title":"Relationship between kalemia and intensive care unit admission or death in hospitalized COVID-19 patients: a cohort study","volume":"47","author":"Gu\u00e9don","year":"2022","journal-title":"J\u00a0Med Vasc"},{"key":"10.1016\/j.jaclp.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.hrthm.2020.04.016","article-title":"Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment","volume":"17","author":"Roden","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaclp.2022.11.001_bib37","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","volume":"17","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaclp.2022.11.001_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40801-022-00300-y","article-title":"Serious cardiovascular adverse events associated with hydroxychloroquine\/chloroquine alone or with azithromycin in patients with COVID-19: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Zhao","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jaclp.2022.11.001_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14182","article-title":"Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: results of a multicenter national survey","volume":"75","author":"Haghjoo","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaclp.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijid.2021.09.036","article-title":"Safety and heart rate changes in Covid-19 patients treated with remdesivir","volume":"112","author":"Brunetti","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaclp.2022.11.001_bib41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/cts.13168","article-title":"Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization International Pharmacovigilance Database","volume":"15","author":"Jung","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaclp.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaclp.2022.11.001_bib43","first-page":"827","article-title":"Cardiac arrhythmias in patients with COVID-19","volume":"36","author":"Wang","year":"2020","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jaclp.2022.11.001_bib44","first-page":"18","article-title":"Sinus bradycardia associated with remdesivir treatment in COVID-19: a case report and literature review","volume":"8","author":"Barkas","year":"2021","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.jaclp.2022.11.001_bib45","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jaccas.2020.08.025","article-title":"Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review","volume":"2","author":"Gubitosa","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jaclp.2022.11.001_bib46","doi-asserted-by":"crossref","first-page":"791.e5","DOI":"10.1016\/j.cmi.2021.02.013","article-title":"Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns","volume":"27","author":"Touafchia","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaclp.2022.11.001_bib47","first-page":"237","article-title":"Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)","volume":"83","author":"Pallotto","year":"2021","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jaclp.2022.11.001_bib48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12012-021-09703-9","article-title":"Potential cardiotoxic effects of remdesivir on cardiovascular system: a literature review","volume":"22","author":"Nabati","year":"2022","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jaclp.2022.11.001_bib49","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/pon.1496","article-title":"Symptoms of post-traumatic stress in children with cancer: does personality trump health status?","volume":"18","author":"Phipps","year":"2009","journal-title":"Psychooncology"},{"key":"10.1016\/j.jaclp.2022.11.001_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jpepsy\/jsm119","article-title":"Symptoms of posttraumatic stress in parents of children with cancer: are they elevated relative to parents of healthy children?","volume":"34","author":"Jurbergs","year":"2009","journal-title":"J\u00a0Pediatr Psychol"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296022006048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296022006048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:45:33Z","timestamp":1757407533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296022006048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2667296022006048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2022.11.001","relation":{},"ISSN":["2667-2960"],"issn-type":[{"type":"print","value":"2667-2960"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-L Case Conference: Torsades de Pointes in a Patient With Lifelong Medical Trauma, COVID-19, Remdesivir, Citalopram, Quetiapine, and Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}